Nexgel Inc (NXGL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nexgel Inc (NXGL) has a cash flow conversion efficiency ratio of -0.141x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-785.00K) by net assets ($5.58 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nexgel Inc - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Nexgel Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NXGL current and long-term liabilities for a breakdown of total debt and financial obligations.
Nexgel Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nexgel Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PayPoint plc
LSE:PAY
|
0.845x |
|
Qualigen Therapeutics Inc
NASDAQ:QLGN
|
-0.056x |
|
SILVER HAMMER MINING CORP
F:7BW0
|
-0.026x |
|
Basin Energy Ltd
AU:BSN
|
-0.041x |
|
CN Asia Corporation Bhd
KLSE:7986
|
0.017x |
|
Bank Permata Tbk
JK:BNLI
|
-0.140x |
|
Nutritional Growth Solutions Ltd
AU:NGS
|
-2.363x |
|
Global Engine Group Holding Limited Ordinary Shares
NASDAQ:GLE
|
-0.028x |
Annual Cash Flow Conversion Efficiency for Nexgel Inc (2016–2024)
The table below shows the annual cash flow conversion efficiency of Nexgel Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see NXGL market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $6.08 Million | $-3.87 Million | -0.636x | -1.54% |
| 2023-12-31 | $5.17 Million | $-3.24 Million | -0.626x | -59.89% |
| 2022-12-31 | $7.64 Million | $-2.99 Million | -0.392x | -71.98% |
| 2021-12-31 | $12.09 Million | $-2.75 Million | -0.228x | +99.10% |
| 2020-12-31 | $71.00K | $-1.80 Million | -25.366x | -431.38% |
| 2019-12-31 | $380.00K | $-1.81 Million | -4.774x | +13.12% |
| 2018-12-31 | $281.00K | $-1.54 Million | -5.495x | -341.98% |
| 2017-12-31 | $625.00K | $-777.00K | -1.243x | +25.05% |
| 2016-12-31 | $794.00K | $-1.32 Million | -1.659x | -- |
About Nexgel Inc
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solut… Read more